GPX4 and systemic lupus erythematosus: The study also revealed the underlying mechanism: autoantibodies and IFN-γ in SLE serum enhance the binding of the transcription suppressor CREMα to the Gpx4 promoter, which in turn suppresses Gpx4 expression.